<?xml version="1.0"?>
<Articles JournalTitle="Journal of Family and Reproductive Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Family and Reproductive Health</JournalTitle>
      <Issn>1735-8949</Issn>
      <Volume>15</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2021</Year>
        <Month>09</Month>
        <Day>07</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Estradiol and COVID-19: Does 17-Estradiol Have  an Immune-Protective Function in Women  Against Coronavirus?</title>
    <FirstPage>150</FirstPage>
    <LastPage>159</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Farideh</FirstName>
        <LastName>Zafari Zangeneh</LastName>
        <affiliation locale="en_US">Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Sarmast Shoushtari</LastName>
        <affiliation locale="en_US">Chemical and Environmental Engineering Department, Engineering Faculty, Malaysia Putra university, Selangor, Malaysia</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>05</Month>
        <Day>16</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>09</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: Female sex hormones have a pro-inflammatory effect, which may help to minimize inflammation. Estrogen's immunoregulatory properties play a significant role in the bi-directional neuroendocrine-immune activity in females. As a result, sex hormones can play a role in men's high mortality rate from coronavirus-2019 (COVID-19). It is aimed to clarify the role of 17-estradiol (E2) in the battle against COVID-19.
Materials and methods: Until April 2021, a study on PubMed was performed. COVID-19, 17-estradiol (E2), immunoregulatory properties, pregnancy, menopausal symptoms, hormonal therapy, 
 ER/ expression on immune cells, and mortality were some of the concepts used in the search.
Results: Regulation of pro-inflammatory immune processes against COVID-19 appears to be associated with increased immune function (pro-inflammatory), anti-inflammatory regulation, and antiviral defense. Women with a severe coronavirus infection had higher serum IgG antibody levels than men, and their IgG production was faster in the early stages of infection. 17-estradiol (E2) levels of blood will increase by 
 100-fold during pregnancy. COVID-19 in pregnant women had a 15-fold lower mortality rate than other women. While menopause replacement therapy (MRT) for pre/post-menopausal women and its effectiveness in reducing COVID-19 infection is debatable.
Conclusion: MRT may be considered as a viable treatment option for pre/post-menopause women with coronavirus, referring to the fact that sex hormones reduce inflammatory responses and modulate 
 ACE2 expression. The task's difficulty and achieving the desired outcome seem to be challenging.
&#xD;

&#xA0;</abstract>
    <web_url>https://jfrh.tums.ac.ir/index.php/jfrh/article/view/1787</web_url>
    <pdf_url>https://jfrh.tums.ac.ir/index.php/jfrh/article/download/1787/576</pdf_url>
  </Article>
</Articles>
